Alto Neuroscience, Inc. Common Stock (ANRO)
Operating Cash Flow Growth
-23.97%
TTM · Period ending:
ANRO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-23.97%period ending
Latest reported-23.97%period ending
ANRO TTM Cash from Operations YoY % (-64.35% → -23.97%)
Year-over-year change
High-resolution chart · PNG
ANRO operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -23.9697% | |
| -17.5614% | |
| -9.162% | |
| -15.9971% | |
| -31.2539% | |
| -43.5961% | |
| -41.7843% | |
| -64.3478% |